ICD Co. Ltd - Asset Resilience Ratio

Latest as of December 2024: 13.84%

ICD Co. Ltd (040910) has an Asset Resilience Ratio of 13.84% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ICD Co. Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩26.46 Billion
≈ $17.93 Million USD Cash + Short-term Investments

Total Assets

₩191.15 Billion
≈ $129.54 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how ICD Co. Ltd's Asset Resilience Ratio has changed over time. See ICD Co. Ltd (040910) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down ICD Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is ICD Co. Ltd worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩23.30 Billion 12.19%
Short-term Investments ₩3.16 Billion 1.65%
Total Liquid Assets ₩26.46 Billion 13.84%

Asset Resilience Insights

  • Moderate Liquidity: ICD Co. Ltd has 13.84% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

ICD Co. Ltd Industry Peers by Asset Resilience Ratio

Compare ICD Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Elite Material Co Ltd
TW:2383
Electronic Components 0.00%
Avary Holding Shenzhen Co Ltd Class A
SHE:002938
Electronic Components -1.69%
WT Microelectronics Co Ltd
TW:3036
Electronic Components 0.14%
Shenzhen Sunway Communication
SHE:300136
Electronic Components 0.03%
Shenzhen Everwin Precision Tech
SHE:300115
Electronic Components 1.62%
TDG Holding Co Ltd
SHG:600330
Electronic Components 1.67%
Guizhou Space Appliance Co Ltd
SHE:002025
Electronic Components -0.32%
Poco Holding Co Ltd
SHE:300811
Electronic Components 6.41%

Annual Asset Resilience Ratio for ICD Co. Ltd (2013–2024)

The table below shows the annual Asset Resilience Ratio data for ICD Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 13.84% ₩26.46 Billion
≈ $17.93 Million
₩191.15 Billion
≈ $129.54 Million
+0.27pp
2023-12-31 13.58% ₩28.06 Billion
≈ $19.01 Million
₩206.66 Billion
≈ $140.05 Million
-5.45pp
2022-12-31 19.03% ₩38.53 Billion
≈ $26.11 Million
₩202.50 Billion
≈ $137.23 Million
-10.58pp
2021-12-31 29.60% ₩68.93 Billion
≈ $46.71 Million
₩232.85 Billion
≈ $157.80 Million
+2.15pp
2020-12-31 27.46% ₩64.01 Billion
≈ $43.38 Million
₩233.10 Billion
≈ $157.97 Million
+17.97pp
2019-12-31 9.49% ₩19.34 Billion
≈ $13.11 Million
₩203.77 Billion
≈ $138.09 Million
+3.88pp
2018-12-31 5.62% ₩10.74 Billion
≈ $7.28 Million
₩191.22 Billion
≈ $129.59 Million
-1.83pp
2017-12-31 7.45% ₩17.60 Billion
≈ $11.93 Million
₩236.23 Billion
≈ $160.09 Million
-4.19pp
2016-12-31 11.64% ₩28.07 Billion
≈ $19.02 Million
₩241.20 Billion
≈ $163.46 Million
+1.98pp
2013-12-31 9.66% ₩12.00 Billion
≈ $8.13 Million
₩124.27 Billion
≈ $84.22 Million
--
pp = percentage points

About ICD Co. Ltd

KQ:040910 Korea Electronic Components
Market Cap
$65.07 Million
₩96.02 Billion KRW
Market Cap Rank
#20861 Global
#1278 in Korea
Share Price
₩5880.00
Change (1 day)
-1.84%
52-Week Range
₩3660.00 - ₩6030.00
All Time High
₩18768.95
About

ICD Co., Ltd. engages in the manufacture and sale of AMOLED, LCD, and semiconductor equipment in South Korea and internationally. The company offers DRY etcher and research-thermal evaporator. It also involves in bio and medical business by using plasma to develop devices and products for sterilization, medicine, cosmetics, etc. The company was founded in 2000 and is headquartered in Anseong-si, … Read more